scholarly article | Q13442814 |
P2093 | author name string | Yang Guo | |
Dan Cheng | |||
Lan Jin | |||
Xueyan Xi | |||
Yunhe Chen | |||
P2860 | cites work | Mst1 and Mst2 kinases: regulations and diseases | Q22001145 |
Hallmarks of Cancer: The Next Generation | Q22252312 | ||
The SLUG zinc-finger protein represses E-cadherin in breast cancer | Q24292674 | ||
Tumor suppressor LATS1 is a negative regulator of oncogene YAP | Q24304725 | ||
TEAD mediates YAP-dependent gene induction and growth control | Q24336045 | ||
Molecular mechanisms of epithelial-mesenchymal transition | Q27013743 | ||
Cancer statistics, 2015 | Q27860576 | ||
Epithelial-mesenchymal transitions in development and disease | Q27860630 | ||
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis | Q28131703 | ||
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? | Q29547559 | ||
The Hippo signaling pathway in stem cell biology and cancer | Q30410176 | ||
KRAS and YAP1 converge to regulate EMT and tumor survival | Q33946244 | ||
Stability of the hybrid epithelial/mesenchymal phenotype | Q34519552 | ||
Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells | Q34770004 | ||
Loss of CDH1 (E-cadherin) expression is associated with infiltrative tumour growth and lymph node metastasis | Q36750694 | ||
The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal | Q37909890 | ||
Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance | Q38148800 | ||
The mammalian Hippo pathway: regulation and function of YAP1 and TAZ. | Q38255378 | ||
Epithelial-mesenchymal transition in colorectal cancer metastasis: A system review | Q38532689 | ||
Elevation of YAP promotes the epithelial-mesenchymal transition and tumor aggressiveness in colorectal cancer. | Q38727766 | ||
EMT: 2016. | Q38883448 | ||
E-cadherin: A potential biomarker of colorectal cancer prognosis. | Q39355560 | ||
TEADs mediate nuclear retention of TAZ to promote oncogenic transformation | Q39867711 | ||
EMT-Regulome: a database for EMT-related regulatory interactions, motifs and network | Q41084261 | ||
Snail/Slug-YAP/TAZ complexes cooperatively regulate mesenchymal stem cell function and bone formation | Q47351013 | ||
Down-regulation of transcription factor OVOL2 contributes to epithelial-mesenchymal transition in a noninvasive type of trophoblast implantation to the maternal endometrium. | Q49374365 | ||
RARγ Downregulation Contributes to Colorectal Tumorigenesis and Metastasis by Derepressing the Hippo-Yap Pathway. | Q51691432 | ||
YAP1 contributes to NSCLC invasion and migration by promoting Slug transcription via the transcription co-factor TEAD. | Q55397079 | ||
Loss of E-Cadherin expression is associated with a poor prognosis in stage III colorectal cancer | Q88070507 | ||
Colorectal cancer cells use the negative feedback regulators of WNT signalling to activate epithelial-mesenchymal transition pathways | Q89911956 | ||
P433 | issue | 4 | |
P921 | main subject | colorectal cancer | Q188874 |
P304 | page(s) | 701-710 | |
P577 | publication date | 2020-04-01 | |
P1433 | published in | International Journal of Clinical and Experimental Pathology | Q6051341 |
P1476 | title | YAP promotes epithelial mesenchymal transition by upregulating Slug expression in human colorectal cancer cells | |
P478 | volume | 13 |
Search more.